1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol
(
- Contribution to journal › Article
- 2023
-
Mark
Neonatal outcomes following early fetal growth restriction : a subgroup analysis of the EVERREST study
(
- Contribution to journal › Article
-
Mark
Maternal PlGF and umbilical Dopplers predict pregnancy outcomes at diagnosis of early-onset fetal growth restriction
(
- Contribution to journal › Article
- 2022
-
Mark
Development of standard definitions and grading for Maternal and Fetal Adverse Event Terminology
(
- Contribution to journal › Article
- 2017
-
Mark
EVERREST prospective study : A 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction
(
- Contribution to journal › Article
- 2015
-
Mark
Does Vascular Endothelial Growth Factor Gene Therapy Safely Improve Outcome in Severe Early-Onset Fetal Growth Restriction? (EVERREST)
(
- Contribution to journal › Article